Relationship of dialysis membrane and cause-specific mortality

American Journal of Kidney Diseases

Volumn 33, Issue 1, 1999, Pages 1-10

  Bloembergen, W E ^a   Hakim, R M ^a   Stannard, D C ^a   Held, P J ^a   Wolfe, R A ^a   Agodoa, L Y C ^a   Port, F K ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Cause of death; Cellulosic; Dialysis; Modified cellulosic; Mortality; Synthetic

Indexed keywords

CELLULOSE;

ADULT; ATHEROGENESIS; CAUSE OF DEATH; CORONARY ARTERY DISEASE; DIALYSIS MEMBRANE; FEMALE; HEMODIALYSIS; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; REVIEW; TREATMENT OUTCOME;

EID: 0032893206     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(99)70251-9     Document Type: Article

References (36)

1. J Chanard JP Brunois S Lavaud O Toupance Long-term results of dialysis therapy with a highly permeable membrane Artif Organs 6 1982 262 266
2. JC Hornberger M Chernew J Petersen AM Garber A multivariate analysis of mortality and hospital admissions with high-flux dialysis J Am Soc Nephrol 3 1992 1227 1237
3. EG Lowrie NL Lew Y Liu Evaluation of facility attributes associated with the standardized mortality ratio (SMR). Internal memorandum 1993 National Medical Care, Lexington, MA
4. Y Koda S Nishi S Miyazaki S Haginoshita T Sakurabayashi M Suzuki S Sakai Y Yuasa Y Hirasawa T Nishi Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients Kidney Int 52 1997 1096 1101
5. RM Hakim PJ Held D Stannard RA Wolfe FK Port JT Daugirdas L Agodoa The effect of the dialysis membrane on mortality of chronic hemodialysis patients (CHD) in the US Kidney Int 50 1996 566 570
6. NW Levin G Zasuwa F Dumler Effect of membrane type on causes of death in hemodialysis patients J Am Soc Nephrol 2 1991 335 (abstr)
7. PJ Held FK Port RA Wolfe DC Stannard CE Carroll JT Daugirdas WE Bloembergen JW Greer RM Hakim The dose of hemodialysis and patient mortality Kidney Int 50 1996 550 556
8. US Renal Data System Researcher's Guide to the USRDS Database 1995 National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
9. JT Daugirdas Second-generation logarithmic estimates of single-pool variable volume of Kt/V: An analysis of error J Am Soc Nephrol 4 1993 1205 1213
10. D Cox Regression models and life tables J Royal Stat Soc 34 1972 187 201
11. RA Wolfe FK Port VM Hawthorne KE Guire A comparison of survival among dialytic therapies of choice: In-center hemodialysis versus continuous ambulatory peritoneal dialysis at home Am J Kidney Dis 15 1990 433 440
12. US Renal Data System Patient mortality and survival Am J Kidney Dis 30 1997 S86 S106
13. US Renal Data System Causes of death Am J Kidney Dis 30 1997 S107 S117
14. LU Mailloux AG Belluci BM Wilkes B Napolitano RT Mossey M Lesser PA Bluestone Mortality in dialysis patients: Analysis of the causes of death Am J Kidney Dis 18 1991 326 335
15. JK Leypoldt AK Cheung CE Carroll D Stannard B Pereira L Agodoa F Port Removal of middle molecules enhances survival in hemodialysis patients J Am Soc Nephrol 7 1996 1454 (abstr)
16. SM Orzol CE Carroll RA Hirth BJG Periera FK Port PJ Held Differences in the cost of hemodialysis by dialyzer membrane J Am Soc Nephrol 7 1996 1460 (abstr)
17. MC Ilvento RA Diez ME Estevez A Quevedo HO Estraviz L Sen Hemodialysis decreases spontaneous migration of polymorphonuclears in chronic renal failure Dial Transplant 21 1992 705 708
18. J Himmelfarb P Zaoui D Holbroook RM Hakim Modulation of granulocyte LAM-1 and MAC-1 during dialysis—A prospective, randomized controlled trial Kidney Int 41 1992 388 395
19. R Vanholder S Ringoir A Dhondt A Hakim Phagocytosis in uremic and hemodialysis patients: A prospective and cross-sectional study Kidney Int 39 1991 320 327
20. R Vanholder S Ringoir Infectious morbidity and defects of phagocytic function in end-stage renal disease: A review J Am Soc Nephrol 3 1993 1541 1554
21. AT Nguyen C Lethia J Zingraff A Herbelin C Naret B Descamps-Latsha Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro with microamounts of whole blood Kidney Int 28 1985 158 167
22. J Himmelfarb J Lazarus R Hakim Reactive oxygen species production by monocytes and polymorphonuclear leukocytes during dialysis Am J Kidney Dis 17 1991 271 276
23. J Himmelfarb RM Hakim Biocompatibility and risk of infection in hemodialysis patients Nephrol Dial Transplant 9 suppl 2 1994 138 144
24. RM Hakim Clinical implications of hemodialysis membrane biocompatibility Kidney Int 44 1993 484 494
25. RM Lindsay P Heidenheim E Spanner C Kortas PG Blake Adequacy of hemodialysis and nutrition—Important determinants of morbidity and mortality Kidney Int 45 suppl 44 1994 S85 S91
26. RM Hakim RL Wingard TA Ikizler RA Parker R Vanholder L Husni TF Parker Effects of biocompatibility on nutritional status in chronic hemodialysis patients (CHD) J Am Soc Nephrol 5 1994 451 (abstr)
27. A Gutierrez A Alvestrand J Bergstrom Membrane selection and muscle protein catabolism Kidney Int 42 1992 S86 S90
28. TF Parker RL Wingard L Husni TA Ikizler RA Parker RM Hakim Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients Kidney Int 49 1996 551 556
29. F Locatelli F Mastrangelo B Redaelli C Ronco D Marcelli G La Greca G Orlandini the Italian Cooperative Dialysis Study Group Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters Kidney Int 50 1996 1293 1302
30. DN Churchill W Taylor RJ Cook P La Plante P Barre P Cartier WP Fay MB Goldstein K Jindal H Mandin JK McKenzie N Muirhead PS Parfrey GA Posen D Slaughter RA Ulan R Werb Canadian hemodialysis morbidity study Am J Kidney Dis 19 1992 214 234
31. DS Seres GW Strain SA Hashim IJ Goldberg NW Levin Improvement of plasma lipoprotein profiles during high-flux dialysis J Am Soc Nephrol 3 1993 1409 1415
32. D Steinberg S Parthasarathy TE Carew JC Khoo JL Witztum Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity N Engl J Med 320 1989 915 924
33. E Maffi R Bellazzi A Gazo M Seccia G Bellomo Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis Kidney Int 46 1994 869 876
34. M Toborek T Wasik M Drozdz M Klin K Magner-Wrobel E Kopieczna-Grzebieniak Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure Metabolism 41 1992 1229 1232
35. A Dasgupta S Hussain S Ahmed Increased lipid peroxidation in patients on maintenance hemodialysis Nephron 60 1992 56 59
36. BN Becker J Himmelfarb WL Henrich RM Hakim Reassessing the cardiac risk profile in chronic hemodialysis patients: A hypothesis on the role of oxidant stress and other nontraditional cardiac risk factors J Am Soc Nephrol 8 1997 475 486